Company Filing History:
Years Active: 2014-2016
Title: **Innovative Contributions of Ole Schou**
Introduction
Ole Schou, an accomplished inventor based in Stensved, Denmark, has demonstrated significant expertise in the field of chromatography. With two patents to his name, his work focuses on advancing methods for protein separation and the regeneration of chromatographic stationary phases. His contributions have been instrumental in the scientific community, particularly in the biopharmaceutical sector.
Latest Patents
Ole Schou's latest patents include:
1. **Regeneration of Chromatographic Stationary Phases** - This patent outlines a novel process for regenerating a chromatographic stationary phase, enhancing the efficiency and reusability of chromatographic techniques.
2. **Purification of Proteins Using Preparative Reverse Phase Chromatography (RPC)** - This invention provides a method for industrial-scale protein separation via reverse phase chromatography utilizing a specialized buffer system and an additional salt, improving the practicality of protein purification for large-scale applications.
Career Highlights
Ole Schou is associated with Novo Nordisk A/S, a leading global healthcare company. His innovative approaches to chromatography are vital for the development of new therapies and pharmaceutical products, showcasing his commitment to advancing technology in medicine.
Collaborations
Throughout his career, Ole has collaborated with esteemed colleagues such as Per Larsen and Eigil Schroder Rasmussen. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the research and development initiatives within their field.
Conclusion
In summary, Ole Schou's contributions to the realm of chromatography highlight his role as a pioneer in developing techniques that facilitate protein purification and stationary phase regeneration. His work, supported by collaborative efforts with other leading experts, continues to influence innovations in the biopharmaceutical industry, ensuring the effectiveness of therapeutic solutions for patients worldwide.